Edition:
United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

22.32CNY
2:59am EDT
Change (% chg)

¥0.27 (+1.22%)
Prev Close
¥22.05
Open
¥22.06
Day's High
¥22.80
Day's Low
¥21.82
Volume
4,184,215
Avg. Vol
3,612,992
52-wk High
¥27.49
52-wk Low
¥18.09

Chart for

About

ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine... (more)

Overall

Beta: 0.80
Market Cap(Mil.): ¥22,986.91
Shares Outstanding(Mil.): 1,042.49
Dividend: 0.18
Yield (%): 0.82

Financials

  Industry Sector
P/E (TTM): -- 30.87 15.95
EPS (TTM): -- -- --
ROI: -- 14.31 15.19
ROE: -- 15.61 13.87

BRIEF-Zhejiang Huahai Pharmaceutical to use $30 mln to acquire shares of Eutilex

* Says co signs agreement to invest $30 million in Eutilex Co.,Ltd, which is mainly engaged in R&D of T cell therapy and antibody therapy products

Sep 05 2017

BRIEF-Zhejiang Huahai Pharmaceutical passes U.S. FDA approval

* Says it received FDA approval for Paroxetine Capsules from U.S Food and Drug Administration

Aug 22 2017

BRIEF-Zhejiang Huahai Pharma's prelim H1 net profit up 14.05 pct y/y

* Says preliminary H1 net profit up 14.05 percent y/y at 295.25 million yuan ($43.73 million)

Jul 26 2017

BRIEF-Zhejiang Huahai Pharmaceutical to pay A shares annual div for FY 2016 on June 14

* Says it will pay cash dividend of 0.18 yuan(before tax)/share for 2016 to shareholders of record on June 13

Jun 06 2017

BRIEF-Zhejiang Huahai Pharmaceutical to pay cash 1.8 yuan per 10 shares as FY 2016 div payment

* Says it plans to pay cash 1.8 yuan per 10 shares as FY 2016 div payment

Apr 25 2017

Earnings vs. Estimates